(R)-Levetiracetam
CAS: 103765-01-1
Ref. 3D-DEA76501
1mg | 400,00 € | ||
2mg | 640,00 € | ||
5mg | 1.017,00 € | ||
10mg | 1.786,00 € | ||
25mg | 2.806,00 € |
Información del producto
- (2R)-2-(2-Oxopyrrolidin-1-yl)butanamide
- (R)-2-(2-Oxopyrrolidin-1-yl)butanamide
- (R)-Etiracetam
- (αR)-α-Ethyl-2-oxo-1-pyrrolidineacetamide
- 1-Pyrrolidineacetamide,a-ethyl-2-oxo-, (R)-
- Ucb-L 060
- 1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (αR)-
Levetiracetam is an antiepileptic drug that belongs to the class of drugs known as pyrrolidone derivatives. It is approved for the treatment of partial seizures, myoclonic seizures, and generalized tonic-clonic seizures. Levetiracetam binds to synaptic vesicle protein 2A at the same site as levetiracetam and prevents the release of neurotransmitters from nerve cells. This binding leads to neuronal death by inhibiting mitochondrial functions and reducing neuronal excitability by blocking voltage-sensitive sodium channels. Levetiracetam has been shown to have a concentration-time curve that is similar to intravenous anaesthetics in animal models. This drug also has a polymerase chain reaction (PCR) assay that can detect whether levetiracetam is present in urine samples; this test can be used as an aid in forensic investigations.
Propiedades químicas
Consulta técnica sobre: 3D-DEA76501 (R)-Levetiracetam
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.